Viewing Study NCT00734435


Ignite Creation Date: 2025-12-24 @ 10:33 PM
Ignite Modification Date: 2025-12-29 @ 7:19 AM
Study NCT ID: NCT00734435
Status: TERMINATED
Last Update Posted: 2012-11-29
First Post: 2008-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects
Sponsor: Orexigen Therapeutics, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module